COT Meeting: 16th May 2023
Last updated: 28 July 2023
On this page
Skip the menu of subheadings on this page.1. Apologies for absence.
2. Draft minutes and reserved minutes of the 28th March meeting TOX/MIN/2023/02.
3. Matters arising.
4. Can coating (Reserved) TOX/2023/23.
5. EFSA opinion on BPA TOX/2023/25.
6. Second draft statement on green tea catechins TOX/2023/26.
7. Discussion paper on novel formulations of supplement compounds designed to increase oral bioavailability TOX/2023/27.
8. Committee Advice on the safety of the extension of use of steviol glycosides (E 960) from stevia leaf extract produced by enzymatic conversion (RP1084) (Reserved) TOX/2023/28.
9. Committee Advice on the safety of the Approval of Steviol Glycosides (E 960) Produced by Yarrowia lipolytica (RP1140) (Reserved) TOX/2023/29.
10. Update on the work of other FSA Scientific Advisory Committees - for information TOX/2023/30.
11. Any other business.
Next meeting of the Committee – Tuesday 11th July at Broadway House, London and via Teams.
Matters arising:
- JEG update.
- 3rd draft roadmap TOX/2023/22.
Media discussed during the meeting
PDF documents on this page are not in a fully accessible format, if you require it to be fully accessible, please see the HTML link for that document.
TOX/MIN/2023/02
Draft minutes of the 28th March 2023 meeting
TOX/2023/22
UK New Approach Methodologies Roadmap (2023) Draft Version 3
TOX/2023/23
(Reserved)
TOX/2023/25
EFSA 2023 re-evaluation of the risk to public health from bisphenol A (BPA) in foodstuffs
TOX/2023/26
Third Draft Statement on the Hepatotoxicity of Green Tea Catechins
TOX/2023/27
TOX/2023/28
(Reserved)
TOX/2023/29
(Reserved)
TOX/2023/30
Update on the work of other Scientific Advisory Committees-May 2023